Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis

1 Aug 2022

Abstract excerpt

Background CLEC5A is a member of the C-type lectin superfamily. It can activate macrophages and lead to a series of immune-inflammation reactions. Previous studies reveal the role of CLEC5A in infection and inflammation diseases. Method We acquire and analyze data from The Cancer Genome Atlas (TCGA) database, Genotype-Tissue Expression (GTEx) database, and other comprehensive databases via GSCALite, cBioPortal,...

Source

Identifiers

PMID: 35979347
DOI: 10.3389/fimmu.2022.831542

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and PrognosisPMID 35979347Read ↗

Identification and characterization of CLEC11A and its derived immune signature in gastric cancerSemantic proximity Read ↗

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinomaSemantic proximity Read ↗

BIRC5 expression correlated with immunosuppressive phenotype and predicted inferior response to immunotherapy in lung adenocarcinomaSemantic proximity Read ↗

Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer AnalysisSemantic proximity Read ↗

CLEC3B as a Prognostic and Immunological Biomarker in Pan-Cancer: Multi-Omics Profiling and Validation in Pancreatic Cancer and ExosomesSemantic proximity Read ↗

Comprehensive pan-cancer analysis of inflammatory age-clock-related genes as prognostic and immunity markers based on multi-omics dataSemantic proximity Read ↗

CCL5 might be a prognostic biomarker and associated with immuno-therapeutic efficacy in cancers: A pan-cancer analysisSemantic proximity Read ↗

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysisSemantic proximity Read ↗

A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity.Semantic proximity Read ↗

A pan-cancer analysis of the oncogenic role of ERCC6LSemantic proximity Read ↗

Immune Profiling and Drug Sensitivity in LUAD: Insights from m5C-Related Ferroptosis Gene AnalysisSemantic proximity Read ↗

BIRC5 as a Potential Biomarker and Therapeutic Target for Lung Adenocarcinoma: A Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.